These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Significance of subjective symptoms and diagnostic criteria in initial forms of cerebral circulation insufficiency].
    Author: Eninia GI, Purinia IV, Robule VKh, Maĭore IKh, Timofeeva TN, Berzina AIa.
    Journal: Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(12):19-23. PubMed ID: 2699140.
    Abstract:
    Piracetam was applied to the treatment of 60 patients with initial manifestations of brain circulation failure and stage I circulatory encephalopathy. The drug exerted a beneficial therapeutic effect by reducing high brain vascular resistance (both extra- and intracranial) and by increasing the lowered volume of pulse fluctuations. It made fibrinolytic blood activity and aggregation of formed elements of the blood return to normal. An appreciable antiatherogenic effect was discovered as well. It should be taken into consideration that in patients with a dramatic lowering of pulse fluctuations, the use of piracetam in a dose of 1.6 g/day may enhance headache. In such cases the dose should be reduced.
    [Abstract] [Full Text] [Related] [New Search]